Annual EBITDA:
-$200.20M-$29.06M(-16.98%)Summary
- As of today, CNTA annual EBITDA is -$200.20 million, with the most recent change of -$29.06 million (-16.98%) on December 31, 2024.
- During the last 3 years, CNTA annual EBITDA has fallen by -$60.92 million (-43.74%).
- CNTA annual EBITDA is now -6228.55% below its all-time high of -$3.16 million, reached on December 31, 2020.
Performance
CNTA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$55.07M-$24.39M(-79.52%)Summary
- As of today, CNTA quarterly EBITDA is -$55.07 million, with the most recent change of -$24.39 million (-79.52%) on June 1, 2025.
- Over the past year, CNTA quarterly EBITDA has dropped by -$11.28 million (-25.75%).
- CNTA quarterly EBITDA is now -221.75% below its all-time high of $45.23 million, reached on December 1, 2020.
Performance
CNTA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$206.05M-$11.28M(-5.79%)Summary
- As of today, CNTA TTM EBITDA is -$206.05 million, with the most recent change of -$11.28 million (-5.79%) on June 1, 2025.
- Over the past year, CNTA TTM EBITDA has dropped by -$51.45 million (-33.28%).
- CNTA TTM EBITDA is now -555.52% below its all-time high of $45.23 million, reached on December 1, 2020.
Performance
CNTA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CNTA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -17.0% | -25.8% | -33.3% |
| 3Y3 Years | -43.7% | +18.8% | +2.6% |
| 5Y5 Years | -3955.0% | -221.8% | -555.5% |
CNTA EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -43.7% | +4.7% | -79.5% | +25.2% | -33.3% | +7.2% |
| 5Y | 5-Year | -6228.6% | +4.7% | -221.8% | +25.2% | -555.5% | +7.2% |
| All-Time | All-Time | -6228.6% | +4.7% | -221.8% | +25.2% | -555.5% | +7.2% |
CNTA EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$55.07M(-79.5%) | -$206.05M(-5.8%) |
| Mar 2025 | - | -$30.68M(+58.4%) | -$194.77M(+2.6%) |
| Dec 2024 | -$200.20M(-17.0%) | -$73.66M(-57.9%) | -$199.93M(-23.8%) |
| Sep 2024 | - | -$46.64M(-6.5%) | -$161.50M(-4.5%) |
| Jun 2024 | - | -$43.79M(-22.2%) | -$154.60M(+2.0%) |
| Mar 2024 | - | -$35.83M(-1.7%) | -$157.74M(+7.8%) |
| Dec 2023 | -$171.13M(+18.5%) | -$35.24M(+11.3%) | -$171.14M(+3.7%) |
| Sep 2023 | - | -$39.74M(+15.3%) | -$177.78M(+4.7%) |
| Jun 2023 | - | -$46.93M(+4.7%) | -$186.62M(+10.1%) |
| Mar 2023 | - | -$49.23M(-17.6%) | -$207.47M(+0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$210.02M(-50.8%) | -$41.88M(+13.8%) | -$209.16M(+5.8%) |
| Sep 2022 | - | -$48.58M(+28.3%) | -$221.92M(-4.9%) |
| Jun 2022 | - | -$67.79M(-33.1%) | -$211.47M(-21.8%) |
| Mar 2022 | - | -$50.92M(+6.8%) | -$173.60M(-22.5%) |
| Dec 2021 | -$139.28M(-4302.9%) | -$54.64M(-43.3%) | -$141.70M(-238.8%) |
| Sep 2021 | - | -$38.13M(-27.5%) | -$41.83M(-1030.2%) |
| Jun 2021 | - | -$29.92M(-57.3%) | -$3.70M(-114.1%) |
| Mar 2021 | - | -$19.02M(-142.0%) | $26.22M(-42.0%) |
| Dec 2020 | -$3.16M(+35.9%) | - | - |
| Dec 2020 | - | $45.23M | $45.23M |
| Dec 2019 | -$4.94M | - | - |
FAQ
- What is Centessa Pharmaceuticals plc annual EBITDA?
- What is the all-time high annual EBITDA for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc annual EBITDA year-on-year change?
- What is Centessa Pharmaceuticals plc quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc quarterly EBITDA year-on-year change?
- What is Centessa Pharmaceuticals plc TTM EBITDA?
- What is the all-time high TTM EBITDA for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc TTM EBITDA year-on-year change?
What is Centessa Pharmaceuticals plc annual EBITDA?
The current annual EBITDA of CNTA is -$200.20M
What is the all-time high annual EBITDA for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high annual EBITDA is -$3.16M
What is Centessa Pharmaceuticals plc annual EBITDA year-on-year change?
Over the past year, CNTA annual EBITDA has changed by -$29.06M (-16.98%)
What is Centessa Pharmaceuticals plc quarterly EBITDA?
The current quarterly EBITDA of CNTA is -$55.07M
What is the all-time high quarterly EBITDA for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high quarterly EBITDA is $45.23M
What is Centessa Pharmaceuticals plc quarterly EBITDA year-on-year change?
Over the past year, CNTA quarterly EBITDA has changed by -$11.28M (-25.75%)
What is Centessa Pharmaceuticals plc TTM EBITDA?
The current TTM EBITDA of CNTA is -$206.05M
What is the all-time high TTM EBITDA for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high TTM EBITDA is $45.23M
What is Centessa Pharmaceuticals plc TTM EBITDA year-on-year change?
Over the past year, CNTA TTM EBITDA has changed by -$51.45M (-33.28%)